FDA Warns Against ‘Life-Threatening’ Weight Loss Drugs From California Facility

The agency received a report from a patient who claimed to have discovered a black matter inside a vial of semaglutide distributed from the facility.

A California-based entity is selling compounded drugs used for weight loss and diabetes management that could pose serious health issues for people, according to a warning from the U.S. Food and Drug Administration (FDA).

The alert was issued for medications compounded and distributed by Fullerton Wellness based in Ontario, California, according to a Nov. 1 FDA statement.